Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9416 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8767 |
High Similarity |
NPD7390 |
Discontinued |
0.8478 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8219 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD943 |
Approved |
0.8188 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8163 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8163 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8163 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8125 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7823 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.758 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7566 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7562 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7557 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7557 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7452 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7439 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.743 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7396 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7317 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7317 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7294 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7283 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD37 |
Approved |
0.7184 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7111 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7111 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7111 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7101 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7099 |
Intermediate Similarity |
NPD920 |
Approved |
0.709 |
Intermediate Similarity |
NPD7874 |
Approved |
0.709 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5401 |
Approved |
0.707 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7069 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7053 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7048 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7018 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD2309 |
Approved |
0.6993 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6989 |
Remote Similarity |
NPD5034 |
Approved |
0.6989 |
Remote Similarity |
NPD5028 |
Approved |
0.6989 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4955 |
Approved |
0.6989 |
Remote Similarity |
NPD4954 |
Approved |
0.6989 |
Remote Similarity |
NPD5026 |
Approved |
0.6989 |
Remote Similarity |
NPD36 |
Approved |
0.6982 |
Remote Similarity |
NPD919 |
Approved |
0.6982 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6981 |
Remote Similarity |
NPD1243 |
Approved |
0.6975 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6954 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD5035 |
Approved |
0.6937 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.6931 |
Remote Similarity |
NPD6973 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD5037 |
Approved |
0.6927 |
Remote Similarity |
NPD5038 |
Approved |
0.6898 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD9493 |
Approved |
0.6887 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD1237 |
Approved |
0.6882 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5951 |
Approved |
0.6872 |
Remote Similarity |
NPD5036 |
Approved |
0.6872 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6857 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6852 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2798 |
Approved |
0.6839 |
Remote Similarity |
NPD6663 |
Approved |
0.6836 |
Remote Similarity |
NPD5039 |
Approved |
0.6832 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6829 |
Remote Similarity |
NPD6273 |
Approved |
0.6821 |
Remote Similarity |
NPD1283 |
Approved |
0.6818 |
Remote Similarity |
NPD4956 |
Approved |
0.6818 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6811 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD9266 |
Approved |
0.6809 |
Remote Similarity |
NPD74 |
Approved |
0.6803 |
Remote Similarity |
NPD9545 |
Approved |
0.6803 |
Remote Similarity |
NPD3091 |
Approved |
0.68 |
Remote Similarity |
NPD3972 |
Approved |
0.68 |
Remote Similarity |
NPD7228 |
Approved |
0.6797 |
Remote Similarity |
NPD5736 |
Approved |
0.6793 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6793 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6788 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6779 |
Remote Similarity |
NPD3026 |
Approved |
0.6779
|
Remote Similarity |
NPD3023 |
Approved |